In a study aimed at identifying new anti-prion compounds we screened a library of 500 Australian marine invertebrate derived extracts using a yeast-based anti-prion assay. This resulted in an extract from the subtropical sponge cf. showing potent anti-prion activity. The bioassay-guided investigation of the sponge extract led to the isolation of three new bioactive polyoxygenated steroids, lamellosterols A-C (-). These sterols were all isolated in low yield, and their structures elucidated by extensive NMR and MS data analysis. Lamellosterols A-C displayed potent anti-prion activity against the [] yeast prion (ECs of 12.7, 13.8, and 9.8 μM, respectively). Lamellosterol A () was further shown to bind to the Parkinson's disease implicated amyloid protein, α-synuclein, and to significantly inhibit its aggregation. Our findings indicate that these polyoxygenated sterol sulfates may be useful compounds to study mechanisms associated with neurodegenerative diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jnatprod.0c01168DOI Listing

Publication Analysis

Top Keywords

potent anti-prion
8
anti-prion activity
8
lamellosterols a-c
8
anti-prion
5
anti-prion α-synuclein
4
α-synuclein aggregation
4
aggregation inhibitory
4
inhibitory sterols
4
sterols sponge
4
sponge study
4

Similar Publications

Prion diseases are invariably fatal neurodegenerative diseases of humans and other animals for which there are no effective treatment options. Previous work from our laboratory identified phenethylpiperidines as a novel class of anti-prion compounds. While working to identify the molecular target(s) of these molecules, we unexpectedly discovered ten novel antiprion compounds based on their known ability to bind to the sigma receptors, σR and σR, which are currently being tested as therapeutic or diagnostic targets for cancer and neuropsychiatric disorders.

View Article and Find Full Text PDF

Prion diseases are invariably fatal neurodegenerative diseases of humans and other animals for which there are no treatment options. Previous work from our laboratory identified phenethyl piperidines as novel class of anti-prion compounds. While working to identify the molecular target(s) of these molecules, we unexpectedly discovered ten novel anti-prion compounds based on their known ability to bind to the sigma receptors, σ R and R, which are currently being tested as therapeutic or diagnostic targets for cancer and neuropsychiatric disorders.

View Article and Find Full Text PDF

Background: Prion diseases involve the conversion of a normal, cell-surface glycoprotein (PrP) into a misfolded pathogenic form (PrP). One possible strategy to inhibit PrP formation is to stabilize the native conformation of PrP and interfere with the conversion of PrP to PrP. Many compounds have been shown to inhibit the conversion process, however, no promising drugs have been identified to cure prion diseases.

View Article and Find Full Text PDF

There is an urgent need to develop disease-modifying therapies to treat neurodegenerative diseases which pose increasing challenges to global healthcare systems. Prion diseases, although rare, provide a paradigm to study neurodegenerative dementias as similar disease mechanisms involving propagation and spread of multichain assemblies of misfolded protein ("prion-like" mechanisms) are increasingly recognised in the commoner conditions such as Alzheimer's disease. However, studies of prion disease pathogenesis in mouse models showed that prion propagation and neurotoxicity can be mechanistically uncoupled and in vitro assays confirmed that highly purified prions are indeed not directly neurotoxic.

View Article and Find Full Text PDF

Quinacrine as a potential treatment for COVID-19 virus infection.

Eur Rev Med Pharmacol Sci

January 2021

Laboratorio de Neuroinmunología y Neurooncología, Instituto Nacional de Neurología y Neurocirugía, Ciudad de México, México.

A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a current outbreak of infection termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 is currently a global pandemic that may cause close to half a billion deaths around the world. Until now, there is no effective treatment for COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!